Voyageur Pharmaceuticals Ltd. VM.V
TSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -725.70K | -456.60K | -620.30K | -951.20K | -387.10K |
| Total Depreciation and Amortization | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 541.90K | 26.00K | -83.40K | 172.40K | 202.80K |
| Change in Net Operating Assets | 478.60K | 310.20K | 438.50K | 134.70K | -49.40K |
| Cash from Operations | 295.00K | -120.20K | -265.00K | -643.90K | -233.50K |
| Capital Expenditure | -28.40K | -19.10K | -65.90K | -83.90K | -14.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -28.40K | -19.10K | -65.90K | -83.90K | -14.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 12.80K | 1.63M | 90.20K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -226.90K | -68.70K | -2.00K |
| Cash from Financing | -- | -- | -153.40K | 1.14M | 62.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 266.50K | -139.20K | -484.30K | 411.70K | -185.30K |